441 related articles for article (PubMed ID: 19428874)
1. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
2. Risks of reintroduction of polio after eradication: the vaccine origin of an outbreak of type 3 poliomyelitis.
Martin J; Ferguson GL; Wood DJ; Minor PD
Dev Biol (Basel); 2001; 105():83-92. PubMed ID: 11763341
[TBL] [Abstract][Full Text] [Related]
3. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
4. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
5. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
6. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.
Martín J; Ferguson GL; Wood DJ; Minor PD
Virology; 2000 Dec; 278(1):42-9. PubMed ID: 11112479
[TBL] [Abstract][Full Text] [Related]
7. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
[TBL] [Abstract][Full Text] [Related]
8. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
9. Paralytic poliomyelitis--United States, 1980-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
[TBL] [Abstract][Full Text] [Related]
10. Poliovirus vaccine options.
Zimmerman RK; Spann SJ
Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
[TBL] [Abstract][Full Text] [Related]
11. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
12. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
Friedrich F
Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
[TBL] [Abstract][Full Text] [Related]
13. Possible global strategies for stopping polio vaccination and how they could be harmonized.
Cochi SL; Sutter RW; Aylward RB
Dev Biol (Basel); 2001; 105():153-8; discussion 159. PubMed ID: 11763323
[TBL] [Abstract][Full Text] [Related]
14. Infectious diseases. Polio outbreak raises questions about vaccine.
Greensfelder L
Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
[No Abstract] [Full Text] [Related]
15. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies.
Minor P
Dev Biol (Basel); 2001; 105():75-80. PubMed ID: 11763340
[TBL] [Abstract][Full Text] [Related]
16. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(40):874-5. PubMed ID: 11666115
[TBL] [Abstract][Full Text] [Related]
17. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
[TBL] [Abstract][Full Text] [Related]
18. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.
Wassilak S; Pate MA; Wannemuehler K; Jenks J; Burns C; Chenoweth P; Abanida EA; Adu F; Baba M; Gasasira A; Iber J; Mkanda P; Williams AJ; Shaw J; Pallansch M; Kew O
J Infect Dis; 2011 Apr; 203(7):898-909. PubMed ID: 21402542
[TBL] [Abstract][Full Text] [Related]
19. Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jan; 50(3):41-2, 51. PubMed ID: 11215882
[TBL] [Abstract][Full Text] [Related]
20. Virology. Poliomyelitis eradication--a dangerous endgame.
Nathanson N; Fine P
Science; 2002 Apr; 296(5566):269-70. PubMed ID: 11951020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
